EX-99.1 2 cns043457_ex99-1.htm Exhibit 99.1 to CNS, Inc. Form 8-K dated July 21, 2004

Exhibit 99.1

NEWS RELEASE


July 21, 2004

Contact:  
Sam Reinkensmeyer Shawn Brumbaugh/Marian Briggs
Chief Financial Officer Padilla Speer Beardsley Inc.
CNS, Inc. (612) 455-1700
(952) 229-1500 sbrumbaugh@psbpr.com
sreinkensmeyer@cns.com mbriggs@psbpr.com
Nasdaq Symbol:   CNXS


FOR IMMEDIATE RELEASE


CNS, INC. DECLARES REGULAR QUARTERLY DIVIDEND

        MINNEAPOLIS, July 21, 2004 – CNS, Inc. (Nasdaq: CNXS), the Breathe Right® company, today announced that its board of directors has declared a regular quarterly cash dividend of five cents per share of common stock. The dividend is payable on September 3, 2004, to shareholders of record on August 20, 2004. The company has approximately 14.0 million shares outstanding.


About CNS, Inc.
CNS, based in Minneapolis, designs and markets consumer health care products, including Breathe Right® nasal strips, Breathe Right Snore Relief™ throat spray, Breathe Right Vapor Shot!™ personal vaporizer and FiberChoice® chewable fiber tablets. The company focuses on better breathing and digestive health products that address important consumer needs within the aging well/self care market. Its common stock is listed on the Nasdaq National Market under the ticker symbol “CNXS.” More information about CNS and its products is available at www.cns.com.

###